Longevity
A theoretical model links circadian collapse to neuronal DNA repair failure in aging
By Life and Health Today Staff, . Life and Health Today.
A paper published in the journal GeroScience proposes a new theoretical model for why neurons accumulate DNA damage as the brain ages, arguing that the problem is not a loss of repair capacity but a loss of repair timing.
The model centres on a protein called tyrosyl-tRNA synthetase, or TyrRS. In its standard role, TyrRS helps build proteins in the cell's cytoplasm. The authors argue it has a second, less understood role: when the cell is not using it for protein synthesis, TyrRS moves into the nucleus, the compartment that holds DNA, and there it coordinates three separate DNA-maintenance processes across the 24-hour cycle. The authors call this architecture the TyrRS cascade.
The central claim is that what matters is not how much TyrRS activity a neuron has on average, but how much that activity swings up and down across the day. According to the model, aging delivers two simultaneous blows to that swing. First, blood levels of the amino acid tyrosine rise with age, which keeps TyrRS locked in its cytoplasmic, protein-building form and out of the nucleus. Second, the brain's circadian clock, the internal system that tracks time of day, loses amplitude, meaning its daily peaks and troughs flatten. The authors argue these two insults together trap the cascade in what they call a frozen-intermediate state, where the rhythm is not gone but its range has collapsed. They add that standard laboratory measurements, which sample tissue at a single time point rather than across the day, would misread this state as normal or even elevated activity, potentially masking the problem in existing data.
The paper places this intracellular repair system alongside a separate, better-known process: the glymphatic system, the brain's extracellular waste-clearance network, which is most active during sleep and which other researchers have described as operating on a roughly 50-second oscillation driven by neuromodulators and blood vessels. The authors propose that both systems fail together through the same mechanism, amplitude collapse, and that this is why sleep disruption and neurodegeneration so often travel together.
Three translational implications follow from the model, according to the authors. Drugs aimed at this system should be given in pulses timed to the circadian cycle rather than as sustained-release formulations, because a constant dose would itself flatten the rhythm the drug is meant to restore. Measuring whether a drug is working would require sampling at multiple time points across the day, not just once. And because both the intracellular repair arm and the extracellular clearance arm fail together, treating only one is predicted to be less effective than treating both.
What this paper does not establish is substantial. The authors are explicit that this is a theoretical model. The paper does not report new experimental data. The three streams of the TyrRS cascade are described as independently supported by prior literature, but the authors state directly that streams 2 and 3 remain model predictions requiring phase-resolved validation, and that current data do not allow a determination of which of three possible stream architectures is actually operating. No human data are presented, and no animal experiments are described in the portion of the paper available. The article notes a limitations section exists but that section was not included in the text provided to this publication, so any caveats the authors themselves identified there are not reported here.
The open question is whether the cascade behaves in living neurons the way the model predicts. The authors list falsifiable experimental predictions, which means the framework can in principle be tested and disproved. What would settle it is phase-resolved measurement, meaning repeated sampling across the full 24-hour cycle, of TyrRS activity and its downstream targets in aging neurons, in animals first and eventually in people. Until that work is done, the TyrRS cascade is a hypothesis, a well-constructed one drawing on established biology, but a hypothesis.
Source: https://link.springer.com/article/10.1007/s11357-026-02532-0